Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)UnknownNCT03076372What this trial is testingA Study Evaluating MM-310 in Patients With Solid TumorsWho this might be right forSolid TumorsUrothelial CarcinomaGastric Carcinoma+9 more Merrimack Pharmaceuticals 34
Early research (Phase 1)Looking for participantsNCT06147037What this trial is testingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more AstraZeneca 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)Ended earlyNCT04989387What this trial is testingStudy of INCA 0186 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsSquamous Cell Carcinoma of the Head and Neck (SCCHN)Gastrointestinal (GI) Malignancies Incyte Corporation 57
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Not applicableLooking for participantsNCT06801899What this trial is testingToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary CancerWho this might be right forPancreatic Cancer Insel Gruppe AG, University Hospital Bern 170
Early research (Phase 1)Ended earlyNCT03525392What this trial is testingStudy to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.Who this might be right forPancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more Ipsen 14
Early research (Phase 1)UnknownNCT03507998What this trial is testingPhase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal TumorsWho this might be right forColorectal AdenocarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+4 more Curegenix Inc. 39
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)WithdrawnNCT06090318What this trial is testingMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossWho this might be right forAdvanced Solid TumorCDKN2ANSCLC+7 more Rain Oncology Inc
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT04262388What this trial is testingA Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck University Health Network, Toronto
Large-scale testing (Phase 3)UnknownNCT02514928What this trial is testingResection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of PancreasWho this might be right forPancreatic Cancer Fudan University 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823What this trial is testingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more Taiho Oncology, Inc. 53
Early research (Phase 1)Looking for participantsNCT05076760What this trial is testingMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer+7 more Memgen, Inc. 40